A study for a 59 year old woman who takes Pradaxa, B12, Enzyme Therapy - from FDA reports


2 females aged 59 (±5) who take the same drugs are studied. This is a personalized study for a 59 year old female patient who has A-Fib. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Apr, 20, 2017

2 females aged 59 (±5) who take Pradaxa, B12, Enzyme Therapy are studied.

Number of reports submitted per year:

Pradaxa, B12, Enzyme Therapy for a 59-year old woman.

Information of the patient in this study:

  • Age: 59
  • Gender: female
  • Conditions: A-Fib
  • Drugs taken:
    • Pradaxa (dabigatran etexilate mesylate)
    • B12 (vitamin b12)
    • Enzyme Therapy (pancreatin)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
1 - 6 months:
6 - 12 months:
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  • joint pain
  • knee joint replacement

Top conditions involved for these people *:

  • Vitamin B12 Deficiency (2 people, 100.00%)
  • Tremor (2 people, 100.00%)
  • Gastroesophageal Reflux Disease (2 people, 100.00%)
  • Crohn's Disease (2 people, 100.00%)
  • Atrial Fibrillation/flutter (2 people, 100.00%)

Top co-used drugs for these people *:

  • Sulfasalazine (2 people, 100.00%)
  • Ranitidine (2 people, 100.00%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: A-fib, B12, Pradaxa, Enzyme therapy

You may be interested in these reviews

More reviews for: A-fib, B12, Pradaxa, Enzyme therapy